Coloplast delivered fiscal second-quarter results that featured progress toward normalized, prepandemic dynamics in the U.S. However, the omicron variant and ongoing lockdowns in China have put slight ...
Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback